STOCK TITAN

Concorde International Group Limited Financials

YOOV
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2025 Currency USD FYE December

This page shows Concorde International Group Limited (YOOV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI YOOV FY2024

Flat sales are masking a cash-conversion reversal, as working capital and reinvestment turned FY2024 into financing-dependent growth.

Sales barely moved between FY2023 and FY2024, yet operating cash flow swung from $791K to -$564K. With accounts receivable still rising, the business appears to be collecting cash more slowly and tying more of each sales dollar up before it reaches the bank, which helps explain why FY2023's profit did not become a durable cash engine.

Capital spending of $1.1M landed on top of negative operating cash flow, pushing free cash flow to -$1.6M. That shortfall was covered by financing inflows rather than internal generation, so FY2024 looked more like an investment year that needed outside support than a self-funding one.

Most of the balance-sheet pressure is not classic borrowing: long-term debt was only $171K against total liabilities of $8.0M. That means the tighter constraint likely sits in everyday obligations and a smaller equity cushion, not in large term loans, and it makes liability growth more informative here than headline debt ratios alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 36 / 100
Financial Health Score 36/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Concorde International Group Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
93

Concorde International Group Limited's revenue declined 1.6% year-over-year, from $10.7M to $10.5M. This contraction results in a growth score of 93/100.

Leverage
82

Concorde International Group Limited carries a low D/E ratio of 0.08, meaning only $0.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 82/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
27

Concorde International Group Limited's current ratio of 1.17 is below the typical benchmark, resulting in a score of 27/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
16

While Concorde International Group Limited generated -$564K in operating cash flow, capex of $1.1M consumed most of it, leaving -$1.6M in free cash flow. This results in a low score of 16/100, reflecting heavy capital investment rather than weak cash generation.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$10.5M
YoY-1.6%

Concorde International Group Limited generated $10.5M in revenue in fiscal year 2024. This represents a decrease of 1.6% from the prior year.

EBITDA
N/A
Net Income
N/A
EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$1.6M
YoY-521.3%

Concorde International Group Limited generated -$1.6M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 521.3% from the prior year.

Cash & Debt
$1.0M
YoY+4.5%

Concorde International Group Limited held $1.0M in cash against $171K in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$1.1M
YoY+158.5%

Concorde International Group Limited invested $1.1M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 158.5% from the prior year.

YOOV Income Statement

Metric Q2'25 Q4'24 Q4'23
Revenue N/A N/A N/A
Cost of Revenue N/A N/A N/A
Gross Profit N/A N/A N/A
R&D Expenses N/A N/A N/A
SG&A Expenses N/A N/A N/A
Operating Income N/A N/A N/A
Interest Expense N/A N/A N/A
Income Tax N/A N/A N/A
Net Income N/A N/A N/A
EPS (Diluted) N/A N/A N/A

YOOV Balance Sheet

Metric Q2'25 Q4'24 Q4'23
Total Assets $14.4M+40.1% $10.3M+20.1% $8.6M
Current Assets $9.2M+70.5% $5.4M+1.7% $5.3M
Cash & Equivalents $2.4M+136.1% $1.0M+4.5% $957K
Inventory N/A N/A N/A
Accounts Receivable $6.3M+64.4% $3.8M+9.7% $3.5M
Goodwill $9K-1.8% $9K-96.9% $297K
Total Liabilities $10.2M+26.9% $8.0M+37.0% $5.8M
Current Liabilities $6.8M+49.3% $4.6M+30.3% $3.5M
Long-Term Debt $230K+34.7% $171K+89.5% $90K
Total Equity $4.2M+86.6% $2.3M-16.4% $2.7M
Retained Earnings -$86.0M-3.2% -$83.3M-46997.9% $178K

YOOV Cash Flow Statement

Metric Q2'25 Q4'24 Q4'23
Operating Cash Flow N/A N/A N/A
Capital Expenditures N/A N/A N/A
Free Cash Flow N/A N/A N/A
Investing Cash Flow N/A N/A N/A
Financing Cash Flow N/A N/A N/A
Dividends Paid N/A N/A N/A
Share Buybacks N/A N/A N/A

YOOV Financial Ratios

Metric Q2'25 Q4'24 Q4'23
Gross Margin N/A N/A N/A
Operating Margin N/A N/A N/A
Net Margin N/A N/A N/A
Return on Equity N/A N/A N/A
Return on Assets N/A N/A N/A
Current Ratio 1.34+0.2 1.17-0.3 1.50
Debt-to-Equity 0.05-0.0 0.08+0.0 0.03
FCF Margin N/A N/A N/A

Frequently Asked Questions

Concorde International Group Limited (YOOV) reported $10.5M in total revenue for fiscal year 2024. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Concorde International Group Limited (YOOV) revenue declined by 1.6% year-over-year, from $10.7M to $10.5M in fiscal year 2024.

As of fiscal year 2024, Concorde International Group Limited (YOOV) had $1.0M in cash and equivalents against $171K in long-term debt.

Concorde International Group Limited (YOOV) generated -$1.6M in free cash flow during fiscal year 2024. This represents a -521.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Concorde International Group Limited (YOOV) generated -$564K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Concorde International Group Limited (YOOV) had $10.3M in total assets as of fiscal year 2024, including both current and long-term assets.

Concorde International Group Limited (YOOV) invested $1.1M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Concorde International Group Limited (YOOV) had a current ratio of 1.17 as of fiscal year 2024, which is considered adequate.

Concorde International Group Limited (YOOV) had a debt-to-equity ratio of 0.08 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2024 data, Concorde International Group Limited (YOOV) had $1.0M in cash against an annual operating cash burn of $564K. This gives an estimated cash runway of approximately 21 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Concorde International Group Limited (YOOV) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top